The rise of artificial intelligence (AI) in healthcare brings new opportunities and challenges for healthcare administrators, owners, and IT managers across the United States. AI technologies promise better efficiency, accuracy, and patient outcomes, especially in tasks like appointment scheduling, patient communication, and care recommendations. Many people in healthcare have expected that human oversight—called the Human-in-the-Loop (HITL) model—would be necessary for keeping trust and safety in AI systems. But recent research asks if this is always true, encouraging healthcare organizations to rethink how they use AI, especially in roles that deal directly with patients.
This article looks at recent findings about how healthcare professional oversight affects trust in AI technologies and how willing patients are to accept AI-driven healthcare recommendations. It also talks about the important role of institutional trust and governance in healthcare AI and explains how AI workflow automations can fit into healthcare operations with the right safeguards.
Trust is key to using AI systems in healthcare. When patients and providers trust AI advice, they are more likely to accept it. This can lead to better health results. The Human-in-the-Loop (HITL) idea says that healthcare professionals should keep watching, checking, and stepping in on AI decisions to build trust. It makes users feel that humans are controlling the machine’s actions.
However, research by Rosemary Tufon, a healthcare researcher at Kennesaw State University, challenges this belief. Her study used survey data from adults in the U.S. aged 18 and older. She used a method called Partial Least Squares Structural Equation Modeling (PLS-SEM) to look at what affects trust in healthcare AI agents.
The study found that important institutional factors—like situational normality, structural assurance, and cognitive reputation—have a big impact on trust. These show how consistent AI systems are in healthcare, the guarantees and protections from healthcare institutions, and the overall reputation of the institutions using AI. In comparison, healthcare professional oversight as a human-in-the-loop factor did not significantly affect users’ trust.
The findings suggest that trust in AI healthcare agents depends more on trust in the institution than on direct human involvement in AI decisions. Situational normality means AI tools are seen as a normal part of healthcare routines. Structural assurance involves laws, privacy protections, and rules that make people confident the organization uses AI safely. Cognitive reputation is how the public sees the healthcare organization’s reliability and skills.
These institutional parts together build the belief that the AI system is reliable and that its results can be trusted. This trust stays strong even without constant human oversight of every AI action.
For healthcare administrators and IT managers, this shows they should focus on securing and sharing these institutional factors instead of depending mainly on clinician involvement to check AI results. Too much focus on human oversight might reduce AI’s possible efficiency without adding much to trust.
The research also looked at whether the seriousness of a disease changes how trust affects acceptance of AI recommendations. The data shows that disease severity does not change how trust affects willingness to accept AI advice. Instead, disease severity itself has its own effect on how willing patients are to accept help from AI.
This means patients with more serious conditions might need more reassurance or may be more careful about health decisions, no matter how much they trust AI. Healthcare organizations should add trust-building steps that fit different patient needs, especially for serious or complex cases.
Besides building trust, good AI governance is important to make patients and providers feel safe about the fairness, privacy, and safety of AI systems. A review by Papagiannidis, Mikalef, and Conboy describes a governance approach with three parts:
Healthcare institutions in the U.S., where rules like HIPAA and state laws require strict data privacy and security, must follow these governance steps. Putting these into the AI life cycle keeps organizations responsible and helps build public trust. It also allows them to develop AI technologies safely.
In many U.S. healthcare places, front-office work like appointment scheduling, phone calls, and patient communication uses a lot of staff time. Simbo AI is one company that offers AI systems to automate phone answering and front-office tasks. These AI tools aim to lower staff workload, quicken call responses, and improve patient experience by automating simple interactions.
From the trust evidence mentioned earlier, these AI systems do not need constant human approval to be trusted if institutions use strong safeguards and clearly share trust information. This changes how administrators and IT managers handle AI workflow:
With this model, healthcare professional oversight changes from real-time control to strategic planning and quality checks. This lets healthcare places get the most benefit from AI tools like Simbo AI’s front-office automation without losing user trust.
Medical administrators, healthcare owners, and IT managers need to reconsider old ideas about human roles in AI workflows. Recent research suggests:
Healthcare leaders should use governance models that include technical checks, legal rules, and patient communication. This combined approach helps use AI well while handling ethical and operational challenges.
In summary, challenges to the Human-in-the-Loop idea from recent studies encourage healthcare administrators and IT workers in the United States to build trust in AI around strong institutional support. Moving away from always needing human oversight toward solid governance, legal protections, and clear communication may better help AI be accepted and fit into healthcare tasks like Simbo AI’s front-office tools. As AI grows in healthcare, leaders must focus on these key trust elements to get the most from the technology while keeping patients safe and respecting their privacy.
The research focuses on understanding the trust-building process in human-AI interactions within healthcare, particularly examining institutional trust factors and human oversight to explain users’ willingness to accept AI-driven healthcare recommendations.
Modeling trust is difficult due to disparities in how trust is conceptualized and measured, and because trust drivers extend beyond system performance to include nuanced factors like institutional accountability and human oversight.
Situational normality, structural assurance, and cognitive reputation are key institutional factors that enhance trusting beliefs in healthcare AI systems.
Contrary to expectations, healthcare professional oversight, as a human-in-the-loop factor, showed no significant impact on users’ trusting beliefs in AI recommendations.
Disease severity does not moderate the relationship between trusting beliefs and acceptance intention but has a direct influence on the willingness to accept AI healthcare recommendations.
The study employed a web survey of U.S. adults aged 18+, analyzing data using Partial Least Squares Structural Equation Modeling (PLS-SEM) to validate the trust model.
Strong institutional safeguards and assurances positively shape patient trust in AI technologies, highlighting the critical role of institutional trust in high-risk settings like healthcare.
The research challenges the HITL model by showing that perceived human oversight may not be essential for building trust or acceptance of AI healthcare recommendations.
Healthcare organizations should focus on creating and communicating reliable institutional safeguards and assurance mechanisms to foster patient trust in AI tools rather than relying solely on human oversight.
Trusting beliefs consistently impact individual intention to accept AI recommendations regardless of disease severity, underscoring trust as a universal driver of acceptance.